Join SightNation!

Become a citizen of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Connect with Colleagues

Link up with professionals all over the nation. Share your ideas, thoughts and opinions. Collaborate on difficult cases and offer your insights.

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling. Post questions to your peers.

Learn and Advance

Take CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on the latest eye care industry news.

Unite!

Engage with SightNation citizens to help create real reform on issues affecting the industry. Start or join groups about the issues most important to you.

Create an account and receive access to the personalized box below.

Apply for Citizenship!
Local Eye Site
view counter

What’s Going On Across the Nation

New Blog Postings

SightNation News

Featured News

A New Tack in Avoiding TED - 03.06.2015

A University of Michigan study reports that patients with Graves’ disease had a significantly reduced risk of developing thyroid eye disease after taking statins or undergoing surgical removal of the More »

Featured News

A New Clue to the Trigger for AMD - 03.05.2015

New research from scientists at the University of Maryland School of Medicine has found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration. More »

Featured News

First Commercial Implants of the Argus II Retinal Prosthesis System in France - 03.04.2015

All three of the centers approved to implant Second Sight Medical Products Inc.'s Argus II Retinal Prosthesis System (“Argus II”) under a French government national healthcare reimbursement program ha More »

Featured News

FDA Approves Lupin’s Generic Lumigan Ophthalmic Solution 0.03% - 03.03.2015

Pharma Major Lupin Limited (Lupin) has received final approval for its bimatoprost ophthalmic solution, 0.03% from the FDA to market a generic version of Allergan's Lumigan Ophthalmic Solution, 0.03%. More »

Cyclo G6 Laser System Cleared by FDA for the Treatment of Multiple Stages of Glaucoma - 03.02.2015

Iridex Corp. recently announced that it has received clearance from the FDA to market its first laser system designed solely for use in treating glaucoma and its symptoms. More »

Copyright © 2010 Jobson Medical Information LLC. All Rights Reserved.